Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D A Stehouwer

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Diabetologia|January 28, 2012
Complement C3: an emerging risk factor in cardiometabolic diseaseE Hertle, M M J van Greevenbroek, C D A Stehouwer
Nederlands Tijdschrift Voor Geneeskunde|November 13, 2008
[Chronic renal disease as cardiovascular risk factor]M M H Hermans, J P Kooman, C D A Stehouwer
Molecular Immunology|July 15, 2014
The complement system in human cardiometabolic diseaseE Hertle, C D A Stehouwer, M M J van Greevenbroek
Current Hypertension Reports|April 24, 2015
Excess cardiovascular risk in diabetic women: a case for intensive treatmentC Recarti, S J S Sep, C D A Stehouwer, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Epidemiology of homocysteine as a risk factor in diabetesA Becker, Y M Smulders, C van Guldener, et al.
The Netherlands Journal of Medicine|June 1, 2013
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequencesM M J van Greevenbroek, C G Schalkwijk, C D A Stehouwer
Nederlands Tijdschrift Voor Geneeskunde|May 5, 2005
[Microvascular dysfunction as an explanation for the metabolic syndrome]E H Serné, R T de Jongh, R G Ijzerman, et al.
Biochemical Society Transactions|December 3, 2003
Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitusM Bourajjaj, C D A Stehouwer, V W M van Hinsbergh, et al.
Journal of Internal Medicine|June 11, 2004
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic reviewM G Wulffelé, A Kooy, D de Zeeuw, et al.
Diabetologia|February 5, 2005
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications StudyM T Schram, N Chaturvedi, C G Schalkwijk, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Diabetologia|January 28, 2012
Complement C3: an emerging risk factor in cardiometabolic diseaseE Hertle, M M J van Greevenbroek, C D A Stehouwer
Nederlands Tijdschrift Voor Geneeskunde|November 13, 2008
[Chronic renal disease as cardiovascular risk factor]M M H Hermans, J P Kooman, C D A Stehouwer
Molecular Immunology|July 15, 2014
The complement system in human cardiometabolic diseaseE Hertle, C D A Stehouwer, M M J van Greevenbroek
Current Hypertension Reports|April 24, 2015
Excess cardiovascular risk in diabetic women: a case for intensive treatmentC Recarti, S J S Sep, C D A Stehouwer, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Epidemiology of homocysteine as a risk factor in diabetesA Becker, Y M Smulders, C van Guldener, et al.
The Netherlands Journal of Medicine|June 1, 2013
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequencesM M J van Greevenbroek, C G Schalkwijk, C D A Stehouwer
Nederlands Tijdschrift Voor Geneeskunde|May 5, 2005
[Microvascular dysfunction as an explanation for the metabolic syndrome]E H Serné, R T de Jongh, R G Ijzerman, et al.
Biochemical Society Transactions|December 3, 2003
Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitusM Bourajjaj, C D A Stehouwer, V W M van Hinsbergh, et al.
Journal of Internal Medicine|June 11, 2004
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic reviewM G Wulffelé, A Kooy, D de Zeeuw, et al.
Diabetologia|February 5, 2005
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications StudyM T Schram, N Chaturvedi, C G Schalkwijk, et al.
Pageof 17